Editorial: Basophil survival and immunomodulatory function are uniquely regulated by a novel MyD88-dependent pathway.
Edward F
EF
Knol
Bernhard F
BF
Gibbs
D000818:Animals; D001491:Basophils / Q000166:cytology / Q000276:immunology*; D002470:Cell Survival / Q000187:drug effects / Q000276:immunology; D002478:Cells, Cultured; D005260:Female; D018793:Interleukin-13 / Q000276:immunology; D020382:Interleukin-18 / Q000276:immunology / Q000494:pharmacology*; D000067596:Interleukin-33; D015847:Interleukin-4 / Q000276:immunology; D007378:Interleukins / Q000276:immunology / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D048308:Mitogen-Activated Protein Kinase 14 / Q000276:immunology*; D053594:Myeloid Differentiation Factor 88 / Q000276:immunology*; D051057:Proto-Oncogene Proteins c-akt / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*
C506535:Il33 protein, mouse; D018793:Interleukin-13; D020382:Interleukin-18; D000067596:Interleukin-33; D007378:Interleukins; C507780:Myd88 protein, mouse; D053594:Myeloid Differentiation Factor 88; D015847:Interleukin-4; D051057:Proto-Oncogene Proteins c-akt; D048308:Mitogen-Activated Protein Kinase 14